Europäische Leitlinien bei der Behandlung alter und gebrechlicher Dialysepatienten

Similar documents
Stadien der Progression bei CKD

Chronic renal disease in the elderly: are all pigs to be considered equal?

Der optimale Dialysebeginn: Full Dose. Full Dose. Ralf Schindler, Nephrologie und Intern. Intensivmedizin, Charité-Virchow Klinikum, Berlin

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

IMPLEMENTATION OF THE CKD-MBD PRACTICE. Goce Spasovski, R. Macedonia

NG U TO D TOCKPHO A is L IN E UPDATE IN GI ONCOLOGY 01. MÄRZ 2019, WIEN

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Palliative Care: European Experience

Publication output in the field of Public Health and its appreciation at political level in Austria

Zukunft Labordiagnostik - wie Medicus helfen kann

SUSPECT ADVERSE REACTION REPORT

SUSPECT ADVERSE REACTION REPORT

Tolvaptan bei ADPKD: Kritische Beurteilung der Studien

FIRST RENAL REPLACEMENT

Geriatric Nephrology. Murtener Tage

Dialysis versus Supportive Care

Nicht-oxidiertes (nox-)pth: ein neuer Marker für CKD-MBD

Dialysis for everyone? Maurizio Gallieni

Bilateral IMA Grafting CONTRA

KDIGO Controversies Conference on Dialysis Initiation, Modality Choice and Prescription. January 25 28, 2018 Madrid, Spain

Operative Urology PDF OPERATIVE UROLOGY. PDF File: Operative Urology 1

EARLY VERSUS LATE STEROID WITHDRAWAL Julio Pascual, Barcelona, Spain Chairs: Ryszard Grenda, Warsaw, Poland

First Interactive Autumn Peritoneal Dialysis School

2017 KDIGO Guidelines Update

Auswertungsbericht Lehrveranstaltungsevaluation an die Lehrenden

Management of Metastatic Bone Pain: Preliminary Results with Single Fraction (4 Gy) Radiotherapy

CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

SFHPT36 Manage the ending of family and systemic therapy

Why do we need guidelines?

Title: Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

Chapter 2: Identification and Care of Patients With Chronic Kidney Disease

Improving Access to Psychological Therapies and care pathways for depression in the UK

SUSPECT ADVERSE REACTION REPORT

Gesundheit in Horizont 2020

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

4/26/2016. Chronic Kidney Disease for PCPs CLAIRE KASSAKIAN, MD NORTHWEST RENAL CLINIC ANNUAL PRACTICAL ADVANCES IN IM SYMPOSIUM

Do We Do Too Many Parathyroidectomies in Dialysis? Sagar Nigwekar MD, MMSc Massachusetts General Hospital

SUSPECT ADVERSE REACTION REPORT

SUSPECT ADVERSE REACTION REPORT

SUSPECT ADVERSE REACTION REPORT

CITRASATE. the citrate-containing concentrate for dialysis. heparin saving improved treatment compatibility reduces oxidative stress and inflammation

Il paziente anziano, evidenza e survey nazionale

Abstract. Introduction. Volume 54 Number 4 Oct. - Dec., Philippine Journal of Internal Medicine. Original Paper

European School of Interventional Radiology (ESIR)

Clinical Policy: Cinacalcet (Sensipar) Reference Number: CP.PHAR.61 Effective Date: Last Review Date: Line of Business: Medicaid

The effect of the refusal avoidance training experiment on final disposition codes in the German ESS-2 Schnell, Rainer; Trappmann, Mark

Welche Bausteine und Vorgehensweisen gehören zur Methodologie des NLP?

SUSPECT ADVERSE REACTION REPORT

Management of the Frail Older Patients: What Are the Outcomes

Newsletter Neurocog. 1/2017 The Neurocognitive Pain Research Group (NCPRG) Year 2017

Introduction to the Concept of Renal Supportive Care. RSC Education Day Elizabeth Josland CNC 2016

ADVANCE CARE PLANNING FOR KIDNEY PATIENTS: THE IMPORTANCE OF AN ONGOING DISCUSSION

PROTECTING HEART, VESSELS, AND BONE: NEW WAYS TO CONTROL PHOSPHORUS

Palliative and End of Life Care in End Stage Renal Disease

The Wennberg International Collaborative, London, 2-4 September 2015

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

(23) (2007) Golden delicious ( ) "Golden delicious" %1 %0.5.%

CKD Prevention Program Protocol

Histopathologie der AV-Gefäßanschlüsse Dr. med. Jan Janzen, MPhil

Valorisation. Valorisation

CAMPUS INNENSTADT. 6. Münchener Kraepelin-Symposium

Ethics of Science and Technology Assessment 20. Functional Foods

The study investigates potential cross-addiction following bariatric surgery.

USRDS UNITED STATES RENAL DATA SYSTEM

SUSPECT ADVERSE REACTION REPORT

NEW NEW NEW. Carbon Dioxide Therapy. The magical formula for beautiful skin and renewed energy

APPLYING KDIGO GUIDELINES TO

Development of tailor-made carbohydrate-based products by bioconversion. German-Russian Forum Biotechnology th of October 2011

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London

SUSPECT ADVERSE REACTION REPORT

The 14th Budapest Nephrology School

Kidney Transplant in the Elderly. Robert Santella, M.D., F.A.C.P.

Sensipar. Sensipar (cinacalcet) Description

HIV-Therapie: Injectables und Generika. Priv.-Doz. Dr. Christoph D. Spinner

OVERVIEW OF COMMENTS RECEIVED ON COMMUNITY HERBAL MONOGRAPH ON CURCUMA LONGA L., RHIZOMA (EMEA/HMPC/456845/2008)

02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?

The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?

GIRL POWER FULL HOUSE STEPHANIE 33 GIRL POWER FULL HOUSE PDF DOWNLOAD GIRL POWER FULL HOUSE STEPHANIE 33 GIRL POWER / FULL HOUSE.

DOWNLOAD OR READ : MANUAL WBC DIFFERENTIAL COUNTER PDF EBOOK EPUB MOBI

Managing Multimorbidity in Everyday Dilemma Situations

Projects: Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Chronic Kidney Disease (CKD) in the Darling Downs- a Registry report

Ramucirumab (colorectal cancer)

Marginal Dialysis: Patient characteristics influencing outcomes

Einführung ins Thema

The Role of Personal and Social Resources and Coping For Finding Meaning in Cancer: A Longitudinal Study

Metaanalytische Evaluierung atypischer Antipsychotika

European Cystinosis Conference. July 13 15, 2018 in Berlin / Germany From innovative science to better clinical care

See Important Reminder at the end of this policy for important regulatory and legal information.

Citrate Anticoagulation

ASN s Legislative Priorities for 2010

Pharmakoepidemiologie: Arzneimittelanwendungsforschung

Kozielecki`s Model of Hope

Dialysis in the elderly and frail patients. Angel LM de Francisco. Hospital Marqués de Valdecilla. Santander

Volume 15 - Issue 3, Cover Story

Title:Pyrosequencing of supra- and subgingival biofilms from inflamed peri-implant and periodontal sites

The role of the Nephrologist in Acute Kidney Injury. Rebecca Brown Consultant Nephrologist Royal Liverpool University Hospital

END - STAGE RENAL DISEASE AND KIDNEY REPLACEMENT THERAPY IN BACHMAI HOSPITAL HANOI - VIETNAM

SUSPECT ADVERSE REACTION REPORT

Transcription:

Europäische Leitlinien bei der Behandlung alter und gebrechlicher Dialysepatienten Prof. Dr. Markus Ketteler markus.ketteler@klinikum-coburg.de Berliner Dialyseseminar, 6. Dezember 2014

Vielseitige Methoden des Shunttrainings

Aber es gibt mehrere Formen des Alterns Healthy Vulnerable Frail

Aber es gibt mehrere Formen des Alterns

Aber es gibt mehrere Formen des Alterns

Aber es gibt mehrere Formen des Alterns

Behandlung alter und gebrechlicher Dialysepatienten Prof. Wim van Biesen: Hi Markus, The elderly guideline is still being developed, so no conclusions there yet. Iattachasummaryofthesurveydonelastyear,asIpresentedattheERA-EDTAfree communications. I also attach an overview of the current guideline project on frail and elderly. Hope this is useful; if you need some other additional info, I do have some general overview papers on different topics in this patient category. Best regards!

Behandlung alter und gebrechlicher Dialysepatienten - Leitlinien

Früher oder später Dialysebeginn die IDEAL Studie

Früher oder später Dialysebeginn die IDEAL Studie

Behandlung alter und gebrechlicher Dialysepatienten - Leitlinien

Behandlung alter und gebrechlicher Dialysepatienten KDIGO CKD-MBD Kommentar Kidney Int 2014 (in press)

Behandlung alter und gebrechlicher Dialysepatienten KDIGO CKD-MBD Kommentar Topic # 1: Vascular calcification Ketteler M et al. Kidney Int2014 (in press)

Altersassoziierte Komplikationen bei medizinischen Entscheidungsprozessen

Inzidenz der Nierenersatztherapie in Altersgruppe

Überlebensprognose im Terminalstadium Dialysepatient vs. Krebspatient vs. Herzversagen

Lebenserwartung und Startmodus der Nierenersatztherapie

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie Carson RC et al. CJASN 2009; 4: 1611

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie Carson RC et al. CJASN 2009; 4: 1611

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie Carson RC et al. CJASN 2009; 4: 1611

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie

Prognosevergleich: Maximal konservatives Management (MCM) vs. Nierenersatztherapie Patienten > 75 Jahre

Komorbiditäten-Scores: Eine Entscheidungshilfe? Body mass index <18.5 kg/m2 (2 points), diabetes (1), congestive heart failure stages III to IV (2), peripheral vascular disease stages III to IV (2), dysrhythmia (1), active malignancy (1), severe behavioural disorder (2), total dependency for transfers (3) and unplanned dialysis (2)

Komorbiditäten-Scores: Eine Entscheidungshilfe?

Komorbiditäten-Scores: Eine Entscheidungshilfe?

Komorbiditäten-Scores: Eine Entscheidungshilfe?

Auswirkungen der Nierenersatztherapie auf den Funktionsstatus im Alter

Auswirkungen der Nierenersatztherapie auf den Funktionsstatus im Alter

Auswirkungen der Nierenersatztherapie auf den Funktionsstatus im Alter

Absetzen der Dialyse welcher Modus?

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage Method An electronic, 36-item survey disseminated among ERA-EDTA members via an e-mail blast. Results In total, 514 nephrologists from 45 European countries completed the survey.: o 36.4% female o 52% >50 years old o 53% in a university centre o 48% practising >20 years o 49% spent >75% of their time in direct patient care. Van Biesen W; personal communication

Van Biesen W; personal communication

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage Percentage of patients withdrawn from dialysis over the last 12 months Van Biesen W; personal communication

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage Physician perception of legal background of dialysis withdrawal Van Biesen W; personal communication

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage Van Biesen W; personal communication

Van Biesen W; personal communication

Behandlung alter und gebrechlicher Dialysepatienten die Umfrage Withdrawal of dialysis occurs with variable frequency over different countries in Europe frequency of withdrawal appears to be associated with: o o o o Perception of legal character Perception of presence of an explicit right on palliative care Health economic model (profit vs not for profit) gender Preparation is suboptimal (even in those centres/countries were withdrawal is more frequent): o o o o no involvement of associated specialties no protocol on who, when, how to organise withdrawal and subsequent PC withdrawal/end of life not part of official nephrology training low interest for CME s on this topic Van Biesen W; personal communication

Vielen Dank für Ihre Aufmerksamkeit! Klinikum Coburg GmbH Prof. Dr. Markus Ketteler Kontaktdaten: Klinikum Coburg GmbH III. Medizinische Klinik: Nephrologie Ketschendorfer Straße 33 96450 Coburg Telefon 09561 22-6329 E-Mail markus.ketteler@klinikum-coburg.de